Table of Contents
Chapter 1: Analysis of Cancer Drugs by Classes (130+ Drug Profiles)
- - BRAND INFORMATION
- Brand and generic name
- Drug class
- Delivery mechanism
- Line of treatment
- - SALES DATA
- Historical/current sales
- Forecasted sales
- - APPROVED INDICATIONS
- - CURRENT PRODUCT DEVELOPMENT PHASES
- - COMPETITIVE AND STRATEGIC POSITIONING
- - MARKET OPPORTUNITIES AND BRAND GROWTH
- - PATENT, GENERIC AND LITIGATION INFORMATION
Chapter 2: Oncology Indications
- - ANALYSIS OF MARKETS FOR DIFFERENT CANCER TYPES
- Current sales, major drugs and important companies
- Forecasted sales and assessment of future drugs and market players
- Pipeline development status
- Major market events, changes in treatments, patent expirations, etc.
Chapter 3: Top Companies' Oncology Portfolios
- - ANALYSIS OF MAJOR ONCOLOGY COMPANIES
- Current sales, major drugs and important companies
- Forecasted sales and assessment of future drugs and market players
- Pipeline development status
|
Related Report
|
View Cart
